Cryoport, Inc.

false 0001124524 0001124524 2026-06-05 2026-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2026 CRYOPORT, INC. (Exact name of registrant as specified in its charter) Nevada 001-34632 88-0313393 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 112 Westwood Place , Suite 350 Brentwood , TN 37027 (Address of principal executive offices, including zip code) Registrant’s telephone number, including area code: ( 949 ) 470-2300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value CYRX The NASDAQ Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ¨ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ Item 5.07 Submission of Matters to a Vote of Security Holders. On June 5, 2026, Cryoport, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The final voting results for the proposals submitted to a vote of stockholders at the Annual Meeting, each of which is described in detail in the Company’s proxy statement filed with the U.S. Securities and Exchange Commission on April 22, 2026 (“Proxy Statement”), are set forth below. Proposal No. 1: Election of Directors . The individuals listed below were elected to serve as directors of the Company until the Company’s 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified or their earlier death, resignation, or removal: Director Nominee Votes For Votes Withheld Broker Non-Votes Linda Baddour 38,883,910 3,835,861 4,507,992 Daniel M. Hancock 40,948,468 1,771,303 4,507,992 Robert Hariri, M.D., Ph.D. 40,675,339 2,044,432 4,507,992 Ram M. Jagannath 40,739,957 1,979,814 4,507,992 Ramkumar Mandalam, Ph.D. 40,356,471 2,363,300 4,507,992 Jerrell W. Shelton 40,937,536 1,782,235 4,507,992 Proposal No. 2: Ratification of the appointment of Deloitte and Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026 . This proposal was approved as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 47,014,962 21,499 191,302 — Proposal No. 3: Advisory vote to approve the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement . This proposal was approved as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 39,533,693 2,390,915 795,163 4,507,992 Proposal No. 4: Amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to, among other things, increase the number of authorized shares under the plan . This proposal was approved as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 30,110,893 12,591,758 17,120 4,507,992 Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Cryoport, Inc. 2018 Omnibus Equity Incentive Plan (as amended, effective June 5, 2026) 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 9, 2026 Cryoport Inc. /s/ Robert Stefanovich Robert Stefanovich Chief Financial Officer